Until recently, life for most people with sickle cell disease was a constant battle. The years were filled with pain, affecting every aspect of life—school, relationships, and work. But then, a new era dawned: a life after sickle cell disease. This is the story of two Americans whose lives were transformed by the advent of newly approved gene therapies. They share their journey with AFP, hoping others will find solace in these groundbreaking treatments. A new technology known as CRISPR/Cas9
